Your browser doesn't support javascript.
loading
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Bossi, P; Miceli, R; Locati, L D; Ferrari, D; Vecchio, S; Moretti, G; Denaro, N; Caponigro, F; Airoldi, M; Moro, C; Vaccher, E; Sponghini, A; Caldara, A; Rinaldi, G; Ferrau, F; Nolè, F; Lo Vullo, S; Tettamanzi, F; Hollander, L; Licitra, L.
Affiliation
  • Bossi P; Head and Neck Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan University of Milan, Milan.
  • Miceli R; Clinical Epidemiology and Trial Organization, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan.
  • Locati LD; Head and Neck Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan University of Milan, Milan.
  • Ferrari D; Medical Oncology, Ospedale San Paolo, Milan.
  • Vecchio S; Medical Oncology, IRCCS San Martino, IST National Cancer Institute, Genova and University of Genova, Genova.
  • Moretti G; Medical Oncology, Azienda Ospedaliera Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia.
  • Denaro N; Medical Oncology, St. Croce & Carle University Teaching Hospital, and ARCO Foundation, Cuneo.
  • Caponigro F; Medical Oncology, Istituto Nazionale Tumori - IRCCS - Fondazione Pascale, Naples.
  • Airoldi M; 2nd Medical Oncology Division, Città della Salute e della Scienza Hospital of Turin, Turin.
  • Moro C; Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo.
  • Vaccher E; Medical Oncology, Centro di Riferimento Oncologico, Aviano.
  • Sponghini A; Medical Oncology, A.O. Universitaria Maggiore della Carità, Novara.
  • Caldara A; Medical Oncology, Ospedale Santa Chiara, Trento.
  • Rinaldi G; Medical Oncology, AOU Policlinico "Paolo Giaccone," Palermo.
  • Ferrau F; Medical Oncology, Ospedale San Vincenzo, Taormina.
  • Nolè F; Medical Oncology, Istituto Europeo di Oncologia, Milan.
  • Lo Vullo S; Clinical Epidemiology and Trial Organization, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan.
  • Tettamanzi F; Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
  • Hollander L; Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
  • Licitra L; Head and Neck Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan University of Milan, Milan. Electronic address: lisa.licitra@istitutotumori.mi.it.
Ann Oncol ; 28(11): 2820-2826, 2017 Nov 01.
Article in En | MEDLINE | ID: mdl-28950305
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Head and Neck Neoplasms / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Head and Neck Neoplasms / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: